SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.480
-0.070 (-4.52%)
At close: Mar 28, 2025, 4:00 PM
1.516
+0.036 (2.45%)
Pre-market: Mar 31, 2025, 8:08 AM EDT
SAB Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.